ABN AMRO in €220m food deal

Swiss pharmaceutical company Norvatis has sold a dietary and slimming products business to ABN AMRO Capital for €220m.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this